PDT dosimetry considerations for Endovascular PDT aimed at downstage Borderline Resectable pancreatic cancers

Lilge L, Vazquez AG, Saeidi T, Verde J, Wanert F, Spiridon IA, Schmid A, Swanstrom L, Bown S, Bogaards A (2025)


Publication Type: Conference contribution

Publication year: 2025

Journal

Publisher: SPIE

Book Volume: 13934

Conference Proceedings Title: Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Event location: Munich, DEU

ISBN: 9781510698055

DOI: 10.1117/12.3097785

Abstract

Targeting pancreatic tumours immediately adjacent to major blood vessels aims to render patients suitable for standard surgical intervention to improve patient prognosis. Delivering the Photodynamic Therapy light endovascularly may achieve this goal, but it requires careful light and drug dosimetry. Building on reported pancreatic tumour and tissue response following interstitial BPD-mediated PDT, the tissues’ responsivities were determined and applied to in silico PDT dosimetry studies. Monte Carlo simulations were employed to determine the endovascular power delivery required to achieve necrotic radii of 5 to 15 mm beyond the arterial or venous wall as a function of the vessel lumen diameter. Pancreatic cancer necrosis up to 15mm deep is attainable adjacent to the blood vessel, albeit with limited selectivity to normal pancreatic tissues. Depending on the vessel’s location, simulations should include adjacent organs. Pre-PDT treatment simulations can assist in designing endovascular PDT to downgrade pancreatic cancer.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Lilge, L., Vazquez, A.G., Saeidi, T., Verde, J., Wanert, F., Spiridon, I.A.,... Bogaards, A. (2025). PDT dosimetry considerations for Endovascular PDT aimed at downstage Borderline Resectable pancreatic cancers. In Zhiwei Huang, Lothar D. Lilge (Eds.), Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Munich, DEU: SPIE.

MLA:

Lilge, Lothar, et al. "PDT dosimetry considerations for Endovascular PDT aimed at downstage Borderline Resectable pancreatic cancers." Proceedings of the 4th Translational Biophotonics: Diagnostics and Therapeutics, Munich, DEU Ed. Zhiwei Huang, Lothar D. Lilge, SPIE, 2025.

BibTeX: Download